Initial patterns of use of COX-2 inhibitors by elderly patients in Ontario: findings and implications.
Mamdani
Muhammad
M
Institute for Clinical Evaluative Sciences, Toronto, ON. muhammad.mamdani@ices.on.ca
Rochon
Paula
P
Laupacis
Andreas
A
Anderson
Geoffrey
G
D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D016527:Drug Costs; D005260:Female; D006801:Humans; D007783:Lactones / Q000008:administration & dosage / Q000191:economics; D008297:Male; D010003:Osteoarthritis / Q000188:drug therapy* / Q000191:economics; D011720:Pyrazoles; D013449:Sulfonamides / Q000008:administration & dosage / Q000191:economics; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib